Anticyclic citrullinated peptide antibodies : the footprint of autoreactive plasma cells in synovium ?

@inproceedings{Teng2007AnticyclicCP,
  title={Anticyclic citrullinated peptide antibodies : the footprint of autoreactive plasma cells in synovium ?},
  author={Yoe Kie Onno Teng and Jacob M. van Laar},
  year={2007}
}

From This Paper

Figures, tables, and topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 105 references

Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF α and IL18 but not CXCL12

  • M van Oosterhout, EW Levarht, JK Sont, TW Huizinga, RE Toes, JM van Laar
  • Ann. Rheum. Dis. 64(4), 537–543
  • 2005
Highly Influential
6 Excerpts

Clinical significance of antibodies to double stranded DNA (dsDNA) for systemic lupus erythematosus (SLE)

  • T Swaak, R Smeenk
  • Clin. Rheumatol. 6(Suppl. 1), 56–73
  • 1987
Highly Influential
11 Excerpts

Anti-B-cell therapy: targetting B-cells in SLE

  • JH Anolik
  • Presented at: EULAR. Barcelona, Spain, June 13–16…
  • 2007
1 Excerpt

Assessment of rituximab’s immunomodulatory synovial effects (the ARISE trial)

  • A Kavanaugh, S Rosengren, SJ Lee
  • I: clinical and synovial biomarker results. Ann…
  • 2007
1 Excerpt

B-cell activity in synovium predicts responsiveness to rituximab in patients with refractory rheumatoid arthritis

  • YK Teng, EW Levarht, M Hashemi
  • Arthritis Rheum. (In Press)
  • 2007
2 Excerpts

Similar Papers

Loading similar papers…